8-K filing — BIP Ventures Evergreen BDC

Kazia Therapeutics Says Paxalisib Phase 1b Data In Six Evaluable Stage IV Triple-Negative Breast Cancer Patients Showed 83% Objective Response Rate, No Treatment-Related Serious Adverse Events

Autodesk Narrows FY2027 Adj EPS Guidance from $12.40-$12.65 to $12.52-$12.60 vs $12.60 Est; Raises FY2027 Sales Guidance from $8.155B-$8.215B to $8.575B-$8.650B vs $8.206B Est

Autodesk (NASDAQ:ADSK) narrows FY2027 Adj EPS guidance from $12.40-$12.65 to $12.52-$12.60 vs $12.60 analyst estimate. Raises FY2027 sales outlook from $8.155 billion-$8.215 billion to $8.575 billion-$8.650 billion vs

Key Tronic Q4 Adj. EPS $(0.26) Up From $(0.35) YoY, Sales $102.027M Down From $110.500M YoY

Key Tronic (NASDAQ:KTCC) reported quarterly losses of $(0.26) per share. This is a 25.71 percent increase over losses of $(0.35) per share from the same period last year. The company reported $102.027 million in sales

Autodesk Widens FY2027 GAAP EPS Guidance from $8.07-$8.63 to $7.89-$8.72 vs $8.44 Est

Autodesk (NASDAQ:ADSK) widens FY2027 GAAP EPS guidance from $8.07-$8.63 to $7.89-$8.72 vs $8.44 analyst estimate..

Autodesk Sees Q3 Adj EPS $3.04-$3.09 vs $3.14 Est; Sees Sales $2.125B-$2.140B vs $2.082B Est

Autodesk (NASDAQ:ADSK) is looking for Q3 Adj EPS of $3.04-$3.09 vs $3.14 analyst estimate. sees sales of $2.125 billion-$2.140 billion vs $2.082 billion analyst estimate.

Rosenblatt Maintains Buy on Meta Platforms, Raises Price Target to $886

Rosenblatt analyst Barton Crockett maintains Meta Platforms (NASDAQ:META) with a Buy and raises the price target from $883 to $886.